Nuwellis to Present at the Oppenheimer 33rd Annual Healthcare Conference
23 févr. 2023 16h15 HE
|
Nuwellis, Inc.
MINNEAPOLIS, Feb. 23, 2023 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company focused on transforming the lives of people with fluid overload, today announced that...
Clinical Data Supports the Role of Ultrafiltration in Preventing Cardiac Surgery-Associated Acute Kidney Injury (AKI)
23 févr. 2023 08h00 HE
|
Nuwellis, Inc.
MINNEAPOLIS, Feb. 23, 2023 (GLOBE NEWSWIRE) -- A recent editorial published in The Annals of Thoracic Surgery provides additional clinical evidence to support the role that ultrafiltration plays in...
Nuwellis, Inc. To Announce Fourth Quarter and Full Year 2022 Financial Results on February 28, 2023
07 févr. 2023 08h00 HE
|
Nuwellis, Inc.
MINNEAPOLIS, Feb. 07, 2023 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company focused on transforming the lives of people with fluid overload, announced today that its...
Nuwellis Reports Preliminary Fourth Quarter and Full Year 2022 Revenue Results
09 janv. 2023 08h00 HE
|
Nuwellis, Inc.
MINNEAPOLIS, Jan. 09, 2023 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE) (“Nuwellis” or the “Company”), a medical technology company focused on transforming the lives of people with fluid...
Nuwellis Appoints Dr. John Jefferies as Chief Medical Officer
05 janv. 2023 14h40 HE
|
Nuwellis, Inc.
MINNEAPOLIS, Jan. 05, 2023 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company focused on transforming the lives of people with fluid overload, today announced the...
Nuwellis, Inc. Announces Passage of Warrant Proposal
04 janv. 2023 17h25 HE
|
Nuwellis, Inc.
MINNEAPOLIS, Jan. 04, 2023 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company focused on transforming the lives of people with fluid overload, today announced that the...
SeaStar Medical and Nuwellis Enter into a U.S. License and Distribution Agreement for SeaStar Medical’s Selective Cytopheretic Device (SCD) for Pediatric Acute Kidney Injury (AKI)
29 déc. 2022 13h35 HE
|
Nuwellis, Inc.
DENVER and MINNEAPOLIS, Dec. 29, 2022 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU) (SeaStar Medical) and Nuwellis, Inc. (Nasdaq: NUWE) (Nuwellis) announce an exclusive U.S....
Nuwellis, Inc. Announces Compliance With Nasdaq Listing Requirements
27 déc. 2022 16h45 HE
|
Nuwellis, Inc.
MINNEAPOLIS, Dec. 27, 2022 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company focused on transforming the lives of people with fluid overload, today announced that on...
Nuwellis Announces Data Supporting Lower Heart Failure Hospitalizations and Readmissions With Aquadex
13 déc. 2022 08h00 HE
|
Nuwellis, Inc.
MINNEAPOLIS, Dec. 13, 2022 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company focused on transforming the lives of people with fluid overload, today announced the...
Nuwellis, Inc. Announces Adjournment of Special Meeting of Stockholders Due to Lack of Quorum
08 déc. 2022 08h10 HE
|
Nuwellis, Inc.
MINNEAPOLIS, Dec. 08, 2022 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company focused on transforming the lives of people with fluid overload, today announced that the...